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Physiol.  247  (Endocrinol.  Metab.  10):  E765-E771,  1984.-The 
aim  of  this  study  was  to  investigate  plasma  free  fatty  acids 
(FFA),  insulin,  and  blood  glucose  during  chemical  stimulation 
of the  lateral  and  ventromedial  hypothalamic  areas  (LHA  and 
VMH)  in  rats.  Therefore  male  Wistar  rats  were  implanted  with 
bilateral  cannulas  in  the  LHA  or  the  VMH  and  into  the  left 
and  right  jugular  veins.  Freely  moving  rats  were  then  infused 
into  the  LHA  and  VMH  with  norepinephrine  (NE),  epineph- 
rine  (E),  or  acetylcholine  or  intravenously  with  NE  or  E.  Before, 
during,  and  after  the  infusions,  simultaneous  blood  samples 
were  taken  without  disturbing  the  animals.  Infusion  of NE  into 
the  LHA  resulted  in  a  decrease  of  plasma  FFA  and  a  simulta- 
neous  increase  of insulin.  NE  infusion  in  the  VMH  elicited  an 
increase  of plasma  FFA,  plasma  insulin,  and  blood  glucose.  E 
infusion  into  the  LHA  did  not  lead  to  a change  of plasma  FFA, 
whereas  insulin  and  glucose  showed  an  increase.  E  infusion 
into  the  VMH  evoked  increases  of  plasma  FFA  and  insulin. 
Peripheral  administration  of NE  led  to  a sharp  increase  of FFA, 
whereas  plasma  insulin  and  blood  glucose  did  not  change.  E  in 
the  periphery  elicited  an  augmentation  of  plasma  FFA  and 
blood  glucose  and  a  suppression  of  insulin  during  infusion. 
After  termination  of E  infusion,  plasma  FFA  and  glucose  levels 
decreased,  whereas  plasma  insulin  showed  a  sharp  increase.  It 
is  concluded  1)  that  the  effects  produced  by  administration  of 
NE  and  E  are  dependent  on  hypothalamic  localization  and 
local  receptor  population  characteristics;  2)  that  there  are  strik- 
ing  differences  regarding  the  effects  on  the  investigated  blood 
parameters  between  hypothalamically  infused  NE  and  E  and 
peripherally  infused  NE  and  E;  and  3)  that  the  LHA  and  VMH 
are  able  to  alter  plasma  FFA  levels  independently  of  blood 
glucose  and  insulin  levels. 
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IN  THIS  STUDY  THE  ROLE  of  chemical  stimulation  of the 
lateral  and ventromedial  hypothalamic  areas (LHA  and 
VMH)  on  plasma  free  fatty  acids  (FFA),  insulin,  and 
blood  glucose is investigated.  It  is well  established  that 
both  the  LHA  and  VMH  can strongly  influence  plasma 
insulin,  glucagon,  and  glucose levels.  Electrical  stimula- 
tion  of the  VMH  of rat  and rabbit  elicits  a rapid  increase 
of  plasma  glucagon  and  blood  glucose (7,  19).  Microin- 
jections  of norepinephrine  (NE)  into  the VMH  of the  rat 
cause a sharp increase of plasma glucagon, plasma insu- 
lin,  and  blood  glucose, whereas a similar  injection  into 
the  LHA  leads to  an immediate  increase only  of plasma 
insulin  (6  1  l 
)A 
C  omparable  response (i.e., i  .ncrease of both 
glucagon and  insulin)  is obtained  in  the  rabbit  after  an 
NE  injection  into  the  VMH.  However,  an  equimolar 
injection  of  epinephrine  (E)  is much more potent  in this 
respect. 
Noradrenergic  stimulation  of  the  LHA  of  rabbits  has 
no  effect  on  plasma  1  .evels of 
glucose, b  ut  adrenergic  stimu 
. 
lati 
insulin,  glucagon ,  and 
.on of the  LHA  in  these 
animals results  in  an  increase of  insulin  but  is without 
effect  on plasma  glucagon  and  glucose (19).  These  data 
indicate  the  existence  of species  differences in the release 
of glucagon and insulin  to catecholaminergic  stimulation 
of the  VMH  and LHA. 
Bolus  injections  as well  as 20-min  infusions  of  small 
amounts of  NE  profoundly  influence  plasma insulin  and 
glucagon levels. Bilateral  infusion  into  the  VMH  of  12.5 
ng  NE/min  for  20 min  leads to  an  increase  of  plasma 
glucagon  and  glucose  throughout  the  infusion  but  is 
without  effect  on insulin  (24). A  similar  infusion  into  the 
LHA,  on the  other  hand,  stimulates  insu  .lin  release and 
strongly  pote ntiates  the  insulin  release to  oral and intra- 
venous  glucose loads (25).  The  results  of  these  experi- 
ments suggest an  . important  role  for  the  hypothalamus 
in  the  release of  those  horm  .ones primari ly  involved  in 
the  regulation  of blood concentrations  of fuel substrates; 
i.e., glucose and FFA.  The  hypothalamus  not  only  affects 
the  function  of  the  islets of  Langerhans,  which  produce 
among  other  hormones  glucagon  and  insulin,  but  also 
the  liver  by  a direct  neural  influence  (20). 
Electrical  or  chemical  stimulation  of  the  VMH  leads 
to  glycogenolysis,  whereas chemical  stimulation  of  the 
LHA  results in  glycogenesis.  In  this  respect  the  neural 
and hormonal  influences  exerted  by  the  VMH  and LHA 
on  blood  glucose levels  are well  documented  (e.g.,  Ref. 
18).  However,  comparable  data  regarding  plasma  FFA 
levels are virtually  absent,  and certainly  none  are avail- 
able  from  unrestrained  freely  moving  rats.  The  finding 
that  dose-dependent  increases of  plasma FFA  follow  an 
injection  of  NE  into  the  lateral  brain  ventricles  of  rats 
suggests  that  central  nervous system (CNS)  mechanisms 
are  involved  (2).  In  another  study  (18),  an  increase  of 
plasma FFA  was found  in  anesthetized  rats during  elec- 
trical  stimulation  of  the  VMH.  However,  this  increase 
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was  absent  during  electrical  stimulation  of  the  VMH  in 
freely  moving  rats. 
The  aim  of  this  study  was  to  clarify  the  role  of  the 
LHA  and  VMH  regarding  the  regulation  of  plasma  FFA 
levels  in  relation  to  the  effects  of  these  areas  on  plasma 
insulin  and  blood  glucose  in  unrestrained  freely  moving 
rats. 
MATERIALS  AND  METHODS 
Animals 
Male  Wistar  rats  weighing  250-300  g at  the  beginning 
of  the  experiments  were  used.  They  were  kept  individ- 
ually  in  Plexiglas  cages  (25  X  25  X  30  cm)  at  room 
temperature  (20  t  2°C)  and  had  continuous  access  to 
standard  carbohydrate-rich  food  (Muracon  laboratory 
chow)  and  water  unless  otherwise  stated.  They  were 
maintained  on  a  12-h  light-dark  cycle  (7:00  A.M.--?00 
P.M.,  light).  The  rats  were  handled  and  weighed  every 
morning  at  about  9:00  A.M. 
Surgery 
All  surgery  was  performed  under  ether  anesthesia.  A 
l-wk  recovery  period  was  allowed  between  subsequent 
surgeries.  The  experiments  started  as  soon  as  the  rat 
returned  to  preoperative  weight.  There  were  no  signifi- 
cant  differences  in  body  weight  of  the  rats  in  the  begin- 
ning  of  an  experiment. 
Implantation  of Brain  Cannulas 
Permanent  stainless  steel cannulas  (21.0  mm  L;  0.3 
mm OD;  0.1 mm ID)  for  drug  infusion  were stereotacti- 
tally  implanted  bilaterally  into  either  the  LHA  or  the 
VMH  according  to the  coordinates  of De Groot  (5) (+5.4 
mm A;  -2.3  mm V;  tl.7  mm L;  and  +5.8  mm A;  -2.7 
mm V;  to.7  mm L,  respectively).  A  sterile  stainless steel 
obturator,  flushed  with  the  tip  of  the  cannula,  was in- 
serted into  each cannula  between  experiments  to  ensure 
that  the  cannula  remained  patent  and pyrogen  free.  The 
cannula  end  protruding  from  the  skull  was protected 
with  a 21-gauge protective  sleeve, except  for  the  last  4 
mm at  the  top  of the  cannula.  The  protective  sleeve was 
affixed  to  the  skull  with  acrylic.  A  piece of polyethylene 
tubing  was put  around  the  cannula  and  obturator.  A 
polyethylene  cap was placed  at the protruding  end of the 
protective  sleeve to  cover  the  free end of the  cannula. 
Implantation  of Heart  Catheters 
All  animals were provided  with  a silicon  heart  catheter 
according  to  the  techniques  described  earlier  (23).  This 
method  allows blood  sampling  in  unanesthetized  undis- 
turbed  freely  moving  rats  (22).  Whenever  intravenous 
infusions  were  to  be performed,  the  rats  were  provided 
with  a  second  silicon  heart  catheter  implanted  in  the 
contralateral  (left)  jugular  vein.  This  smaller  second 
catheter  (0.64 mm OD,  0.28 mm ID)  allows blood to  flow 
from  the  acromiodeltoid  cephalic  and  anterior  jugular 
veins  to  the  external  jugular  vein.  In  general,  rats  did 
not  lose weight  after  implantation  of the second catheter, 
indicating  that  no serious blockade  in venous return  from 
the  head occurred  after  surgery. 
Blood  Sampling  Procedures 
All  experiments  were  performed  between  10:00  and 
12:30 A.M.,  i.e., during  the  light  cycle.  Food was removed 
1.5 h  before  the  start  of  an  experiment.  Blood  samples 
of 0.5 ml were taken  for  determination  of  blood  glucose, 
plasma  insulin,  and  FFA.  Samples were  taken  at  -11, 
-1,  +2,  +7,  +12,  +17,  +22,  +27,  +32,  and  +42  min. 
Infusion  into  either  the brain  or blood circulation  started 
at  time  0.  A  tranfusion  of  titrated  blood,  obtained  by 
means of  a heart  puncture  from  a donor  rat,  was given 
after  each  0.5-ml  sample.  Between  the  withdrawal  of 
blood  samples, the  tip  of  the  heart  catheter  was filled 
with  4 % citrate  solution  (i  nstead  of heparin  solution)  to 
avoid  activation  of endothelial  lipase. 
VMH  and LHA  Infusion  Procedure 
After  removal  of the  cap and obturator,  a sterile  poly- 
ethylene  tubing  (400 mm L,  0.61 mm OD;  0.20 mm ID) 
was inserted  into  each  cannula.  The  tubing  had  been 
previously  filled  with  sterile  test  fluid  except  for  the  last 
8 mm  at  the  distal  end  of  the  tubing,  which  remained 
filled  with  air.  This  end of the  tubing  was sealed off  at 4 
mm.  Thus  any  unwanted  leakage into  the  brain  before 
the  beginning  of the  infusion  was prevented.  Under  the 
sealed end  remained  an  air  bubble  with  a  length  of  4 
mm. After  attachment  of the  tubing  to the  cannulas,  the 
animals were  returned  to  their  cages 30 min  before  the 
start  of  the  experiments.  The  distal end of each infusion 
tubing  remained  outside the  cage so as not  to disturb  the 
animal  (22).  At  the  start  of the  infusion,  the  sealed ends 
of the tubes were cut  off  and the tubing  was immediately 
connected  to  the  infusion  pump.  The  infusion  schedule 
was from  time  0 and  continued  for  20 min  in  all experi- 
ments.  The  beginning  of  movement  of  the  4-mm  air 
bubble was designated  as time 0. Constant  movement  of 
the  air bubble  verified  that  a continuous  infusion  at 0.25 
pl/min  was occurring.  Solutions  of  administered  sub- 
stances were  diluted  with  sterile  saline  from  a  stock 
solution  immediately  before the  start  of the  experiments. 
The  stock  solutions consisted of 1.82 mg NE  tartrate  and 
E  tartrate,  respectively,  (corresponding  with  1 mg  free 
base) dissolved  in  1 ml  distilled  water  containing  1 mg 
Na2S205, 8  mg  NaCl,  and  0.1  mg  Na  EDTA.  Na2S205 
and  EDTA  were added to  prevent  oxidation  of  NE  and 
E.  The  pH  of this  solution  was adjusted to  3.6 by  adding 
2 N  NaOH.  The  animals  received  the  infusions  in  ran- 
dom order  with  at  least  1 day  between  subsequent infu- 
sions. 
Chemical Determinations 
The  blood  samples were  transferred  immediately  to 
chilled  (OOC) centrifuge  tubes containing  10 ~1 heparin 
solution  (500 U/ml)  as an anticoagulant.  Blood  glucose 
was measured by  the  ferricyanide  method  of  Hoffman 
(Technicon  Auto-analyzer  TMII)  with  0.05  ml  blood 
taken  from  the  0.5-ml  sample. The  remaining  0.45 ml of HYPOTHALAMICALLY  INDUCED  FFA  RELEASE  E767 
blood  was  centrifuged  at  4”C,  and  0.15  ml  of  the  super-  TABLE  1.  Basal values t  SE  of FFA, 
natant  was used for  the  FFA  assay, and  the  remaining  glucose, and insulin 
portion  of  the  supernatant  was stored  at  -30°C  for  the 
insulin  assay. Plasma FFA  were determined  according  to 
the  method  of  Antonis  (1).  The  method  was adapted  to 
0.15 ml plasma.  The  plasma for  FFA  determination  was 
extracted  immediately  and  the  evaporated  extracts  were 
stored  at  -30°C  until  FFA  determination.  Rat  specific  ~ 
plasma immunoreactive  insulin  (IRI)  was determined  by  So1vent 
means of  a  radioimmunoassay  kit  (Novo).  Guinea  pig  E 
serum M8309  served as antiserum  for  the  insulin  assay. 
Duplicate  assays were  performed  on  25~1  plasma  sam-  NE 
ples.  The  bound  and  free  1251-labeled  insulin  was sepa- 
rated by  means of  a polyethylene  glycol  solution  (23.75%  ACh 
wt/wt)  as suggested by  Henquin  et al.  (9).  D  ^-A  1 
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Masai  values  k  SE  of  free  fatty  acids  (FFA),  glucose,  and  insulin  as 
His tology 
measured  at  min  1  before  the  start  of  infusion  of  one  of  the  following 
solutions:  solvent,  epinephrine  (E),  norepinephrine  (NE),  or  acetylcho- 
Cannula  placement  was determined  as  follows:  the rats 
line  (ACh).  LHA,  lateral  hypothalamus;  VMH,  ventromedial  hypo- 
thalamus  . 
were  anesthetized  with  ether  and  perfused  with  10% 
Formalin.  The  brains were removed  and stored overnight 
in  10%  Formalin  and  4%  glucose.  The  brains  were 
quickly  frozen  in  melting  isopentane  (-80°C)  and cut  at 
40 pm on a cryostat  microtome.  Brain  slices  were stained 
with  cresyl  fast  violet,  examined  under  a  light  micro- 
scope, and compared with  the  atlas of De Groot  (5).  Only 
the  results of  rats with  correct  cannula  placements,  i.e., 
in  the  VMH  or LHA,  were used. 
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Wilcoxon  matched-pairs  signed-ranks  test  was used 
when  levels  of  blood  components  obtained  during  neu- 
rotransmitter  infusion  in  either  the  brain  or  the  blood  _ 
circulation  were compared  with  basal preinfusion  values.  S 
A  Mann-Whitney  U  test  was applied  if  levels of  blood  T  -I’ 
components  obtained  during  neurotransmitter  infusion 
into  the brain  were compared with  those obtained  during 
diluted  solvent  infusion  into  the  brain.  The  criterion  of 
significance  was set at P  <  0.05. 
EXPERIMENTAL  PROCEDURES  AND  RESULTS 
Experiment  1 
s  .- 
Q  -2o- 
INFUSION  LHA  INFUSION  VMH 
I  ,  +$i.+zT  .,.  1  ,  ,  1  I  I  1 
-10  -1  0  20  40  -10  -1  0  20  40  min  Infusion  of NE  in the LHA  and  VMH.  NE  was infused 
bilaterally  into  the  VMH  of  six  animals  and  into  the 
LHA  of  nine  animals  at  a rate  of  25 ng/min  for  20 min. 
This  quantity  of  NE  was  chosen  because the  largest 
increase  of  insulin  levels  was obtained  with  this  dose 
(25).  As  controls  for  experiments  1  and  2,  seven  rats 
provided  with  VMH  and  LHA  cannulas  were  infused 
with  solvent  for  NE  and  E,  diluted  in  the  same way  as 
the  NE  and  E  solutions,  into  the  VMH  and  LHA  at  a 
rate  of  0.25 pl/min  for  20 min. 
Results. The  data  from  this  experiment  are presented 
in  Table  1 and  Fig.  1. Infusion  of  NE  into  the  LHA  led 
to  a decrease of FFA  during  the  whole period  of infusion 
from  a basal level of 0.19 t  0.023 peq/ml  plasma, whereas 
infusion  of  diluted  solvent  into  the  LHA  elicited  a sig- 
nificant  increase in  FFA  levels after  termination  of  NE 
infusion.  Insulin  increased  significantly  from  a  basal 
level of  25 t  2 pU/ml  plasma during  infusion  and  most 
FIG.  1.  Effects  of  norepinephrine  (NE)  infusion  (25  ng  l  min-’  . can- 
nula  at  a  rate  of  0.25  pl/min  during  20  min)  (M  )  and  diluted 
solvent  infusion  (at  a  rate  of  0.25  pl/min)  (O---O)  in  lateral  hypothal- 
amus  (LHA)  (left  panel)  and  in  ventromedial  hypothalamus  (VMH) 
(right  panel)  on  plasma  free  fatty  acids  (FFA),  blood  glucose,  and 
plasma  insulin.  Data  are  means  k  SE;  peq/ml  plasma,  mg/dl  blood, 
and  pU/ml  plasma,  respectively,  changes  from  preinfusion  levels  of 
FFA,  glucose,  and  insulin,  which  were  average  of  those  of  min  1  before 
infusion  start.  *Denotes  a  significant  change  from  preinfusion  level. 
**Denotes  a  significant  change  from  diluted  solvent  infusion. 
time  points  after  infusion.  Diluted  solvent  infusion  into 
the  LHA  did  not  result  in  an increase of plasma insulin. 
Regarding  glucose,  no  change  from  basal  preinfusion 
levels was present  during  either  NE  infusion  or  diluted 
solvent  infusion  in  the  LHA. 
Infusion  of  NE  into  the  VMH  elicited  a  significant 
increase of  FFA  from  a basal level  of  0.13 t  0.029 peq/ E768  STEFFENS,  DAMSMA,  GUGTEN,  AND  LUITEN 
ml plasma  during  the  later  part  of  the  infusion  period 
and  immediately  afterward.  Infusion  of  diluted  solvent 
into  the  VMH  did  not  result  in  a change of  FFA  during 
infusion.  After  termination  of  infusion,  an  increase was 
observed.  Insulin  increased  significantly  from  a  basal 
level  of  33 t  2 &J/ml  during  NE  infusion  and  at  most 
time  points after  termination  of infusion.  Diluted  solvent 
infusion  into  the VMH  did not  cause a significant  change 
in  insulin.  Glucose  was slightly  augmented  during  NE 
infusion  into  the  VMH  and  immediately  afterward, 
whereas blood  glucose did  not  differ  from  basal values 
during  diluted  solvent  infusion  into  the  VMH. 
Experiment  2 
Infusion  of E  in  the LHA  and  VMH.  The  same animals 
were  used as in  experiment  1.  They  received  bilateral 
infusion  of  25 ng E/min  for  20 min. 
ResuZts. Table  1  shows the  basal FFA,  insulin,  and 
glucose levels and Fig.  2 their  changes during  infusion  of 
E into  the  LHA  and VMH.  Infusion  of  E  into  the  LHA 
resulted  in  a nonsignificant  increase  of  FFA,  which  did 
not  differ  from  the  FFA  values obtained  during  diluted 
solvent  infusion.  Both  insulin  and glucose increased sig- 
nificantly  above  base-line  levels  at  most  time  points 
during  and  after  infusion  of  E. 
Infusion  of  E  into  the  VMH  elicited  an FFA  increase 
in the  later  portion  of  the  infusion  period,  which  contin- 
ued  after  termination  of  infusion.  E  infusion  into  the 
VMH  caused an augmentation  of insulin  above base line. 
During  E  infusion  into  the  VMH,  glucose did  not  differ 
z  0.08 
-E 
3 I 
a  -2o-  INFUSION  LHA 
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-10  -1  0  20  40  -10  -1  0  20  40  min 
FIG.  2.  Effects of epinephrine  (E)  infusion  (25  ng  l  min-l  l  cannula  at 
a  rate  of  0.25  pl/min  during  20  min)(M  )  and  diluted  solvent 
infusion  (at  a rate  of 0.25  pl/min)  (O---O)  in  LHA  (left panel)  and  in 
VMH  (right  panel)  on  plasma  FFA,  blood  glucose,  and  plasma  insulin. 
See Fig.  1  for  further  explanation. 
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FIG.  3.  Mean  changes  t  SE  of plasma  FFA  (peq/ml),  blood  glucose 
(mg/dl),  and  plasma  insulin  (&J/ml)  from  preinfusion  levels,  which 
are  average  of those  of min  1  before  infusion  start,  during  intravenous 
NE  infusion  (left panel)  and  intravenous  E  infusion  (right  panel)  at  a 
rate  of 50 ng/min.  See Fig.  1 for  further  explanation. 
from basal values or from glucose values observed during 
diluted  solvent  infusion. 
Experiment  3 
Infusion  of  NE  and  E  into  the  blood circulation.  NE 
and E were infused  into  the  blood  of  six  rats at  a rate  of 
50 ng/min  and dissolved in  0.02 ml saline for  20 min. 
ResuZts. The  results of  this  experiment  are described 
in  Table  1 and  Fig.  3.  Intravenous  NE  infusion  for  20 
min  elicited  a  sharp  increase  in  FFA  during  and  after 
infusion.  Insulin  showed a small decrease, whereas glu- 
cose did not  differ  from basal values.  On the  other  hand, 
an intravenous  E infusion  for  20 min caused a significant 
increase of  FFA  only  during  the  E  infusion  period,  and 
thereafter  they  decreased to  preinfusion  levels.  Insulin 
decreased significantly  during  E  infusion  and  increased 
significantly  after  termination  of  E  infusion.  Glucose 
showed a sharp  increase during  E  infusion  and reached 
a peak value  at  min 27, whereupon  a decrease followed. 
Experiment  4 
Infusion  of acetylcholine  (ACh)  in  the  LHA  and  VMH. HYPOTHALAMICALLY  INDUCED  FFA  RELEASE 
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FIG.  4.  Effects  of acetylcholine  (ACh)  infusion  (25  ng. min-‘*can- 
nula  at a rate  of 0.25  pl/min  during  20 min)(M  ) and  diluted  solvent 
infusion  (at  a rate  of 0.25  pl/min)@--4)  in  LHA  (left panel)  and  in 
VMH  (right  panel)  on  plasma  FFA,  blood  glucose,  and  plasma  insulin. 
See Fig.  1. for  further  explanation. 
The  same  animals  as  used  in  Experiments  1  and  2  re- 
ceived  bilaterally  an  infusion  of  25  ng  ACh/min  for  20 
min. 
Results. The  data  from  this  experiment  are  presented 
in  Table  1 and  Fig.  4. Infusion  of ACh  into  the  LHA  had 
no  influence  on  FFA  levels.  Although  FFA  were  lower 
during  ACh  infusion  than  during  diluted  solvent  infu- 
sion,  the  difference  did  not  attain  statistical  significance. 
Neither  insulin  nor  glucose  differed  from  basal  levels, 
nor  did  they  differ  from  values  obtained  during  infusion 
of diluted  solvent  into  the  LHA.  ACh  infusion  into  the 
VMH  did  not  elicit  increases  in  FFA  levels  and  the  FFA 
profile  was very  similar  to  that  observed  during  diluted 
solvent  infusion.  Also,  glucose  and  insulin  levels  showed 
only  minor  changes  compared  with  diluted  solvent  infu- 
sion,  except  for  time-point  2 min,  where  insulin  increased 
significantly. 
DISCUSSION 
The  most  conspicuous  results  of this  study  are  1)  the 
decrease  of FFA,  which  is accompanied  by  a simultaneous 
increase  of  insulin  during  noradrenergic  stimulation  of 
the  LHA;  2)  the  elevation  of FFA,  glucose,  and  insulin 
during  noradrenergic  stimulation  of  the  VMH;  3)  the 
absence  of  an  effect  of  adrenergic  stimulation  on  FFA 
levels  but  with  elevations  of glucose  and  insulin;  4)  the 
increase  of  FFA  and  insulin  during  adrenergic  stimula- 
tion  of  the  VMH;  and  5)  the  absence  of >an  effect  of 
cholinergic  stimulation  of the  LHA  and  VMH  except  for 
a  small  increase  of  insulin  during  stimulation  of  the 
VMH. 
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It  is  clear  from  this  study  that  the  effects  of adminis- 
tration  of  NE  and  E  into  the  hypothalamus  are  the 
opposite  of  that  observed  following  peripheral  adminis- 
tration.  Accordingly,  the  observed  effects  of  central 
administration  of NE  and  E  cannot  be  accounted  for  by 
leakage  of  NE  and  E  from  the  brain  into  the  periphery. 
Peripheral  infusion  of  NE  leads  to  a  sharp  increase  of 
plasma  FFA,  whereas  glucose  does  not  change  and  insu- 
lin  is  only  slightly  suppressed.  The  picture  is  different 
during  E  infusion:  both  FFA  and  glucose  levels  increase 
strongly  and  there  is  a  simultaneous  suppression  of  in- 
sulin. 
After  termination  of E  infusion,  insulin  shows  a sharp 
increase  while  FFA  and  glucose  decrease.  It  is  generally 
assumed  that  lipolysis  occurring  in  adipocytes  and  the 
concomitant  increase  of FFA  is caused  by  a ,&-adrenergic 
mechanism  where  as-adrenoreceptor  stimulation  sup- 
presses  lipolysis  (21).  Likewise,  insulin  release  from  the 
B-cell  of the  islets  of  Langerhans  is  stimulated  by  a  ,& 
adrenoreceptor  mechanism  (15)  and  counteracted  by  an 
cw2-adrenoreceptor  mechanism  (14).  It  has  to  be  taken 
into  consideration  that  both  NE  and  E  are potent  CY-  and 
P-receptor  agonists.  In  our  study  we found  an  increase 
of FFA  during  both  NE  and  E  infusions  in  the  periphery. 
After  termination  of infusion,  FFA  continued  to  increase 
in  the  experiment  giving  NE,  whereas  FFA  decreased  in 
the  experiment  giving  E.  Also,  E  infusion  suppressed 
insulin  more  than  NE  infusion  (see Fig.  3).  These  obser- 
vations  indicate  that  the  dose  of  E  (50  ng/min)  admin- 
istered  in  this  study  has  a  stronger  cwz-adrenoreceptor 
effect  than  the  same  dose  of NE.  Apart  from  this  more 
powerful  a2-adrenoreceptor  effect  of E,  which  prevents 
FFA  from  increasing  sharply,  the  hyperglycemia  pro- 
duced  by  E  infusion  may  also  have  counteracted  the 
mobilization  of  FFA,  i.e.,  hyperglycemia  increases  the 
reesterification  of FFA  within  the  adipocyte  (8), although 
it  must  be  admitted  in  this  case  that  insulin  is  not 
suppressed  enough  to  counteract  this  reesterification. 
The  previously  reported  escape  of  insulin  inhibition, 
which  is  caused  by  NE  and  E  infusion,  due  to  concomi- 
tant  hyperglycemia  is  absent  (10).  This  lack  of  escape 
can  probably  be  attributed  to  the  short  period  of  E 
administration  (20  min).  The  decrease  of  FFA  after 
termination  of  E  infusion  can  be  explained  by  the  fact 
that  the  release  of  inhibition  of  the  B-cell  leads  to  an 
immediate  increase  of insulin  because  of the  high  glucose 
levels.  The  combined  high  glucose  and  insulin  levels 
result  in  an  immediate  suppression  of  lipolysis  and  a 
stimulation  of  lipogenesis  so  that  a  decrease  of  FFA 
ensues. 
A  completely  different  picture  is  obtained  after  infu- 
sion  of either  NE  or  E  into  the  hypothalamus.  Available 
data  regarding  plasma  FFA  changes  after  noreadrenergic 
manipulation  of the  CNS  in  rats  suggest  that  adminis- 
tration  of NE  in  the  lateral  ventricle  induces  an  increase 
in  plasma  FFA  (2).  Barbosa  and  Migliorini  (2)  injected 
rather  high  concentrations  of NE  into  the  lateral  ventri- 
cles  (4.225 ng-67.600  ng)  and  withdrew  blood  by  cutting 
the  tip  of  the  tail.  In  previous  studies  we  found  that 
noradrenergic  stimulation  of the  VMH  and  LHA  elicits 
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release  of  glucagon  and  insulin  was  mediated  by  the 
sympathetic  and  parasympathetic  nervous  system  (24, 
25).  Because  white  adipose  tissue  receives  sympathetic 
fibers  which  stimulate  adipocytes  either  directly  or  in- 
directly  via  local  release  of NE  (3),  it  might  be  surmised 
that  the  LHA  and  VMH  areas,  which  are  responsible  for 
the  observed  neural  regulation  of  the  function  of  the 
islets  of Langerhans,  are  also  involved  in  the  regulation 
of FFA  from  the  adipocytes.  Indeed  the  presented  data 
show that  noradrenergic  stimulation  of  the  VMH  and 
LHA  elicits  an increase  and  decrease  respectively  of FFA, 
thus  indicating  that  these  areas  of the  CNS  are  respon- 
sible  for  the  observed  phenomena.  Only  increases  of FFA 
have  been  previously  described  after  CNS  manipulation 
with  neurotransmitters.  The  increase  of  FFA  after 
noradrenergic  stimulation  of the  VMH  can  probably  not 
be  accounted  for  by  a  concomitant  increase  of glucagon, 
which  has  been  reported  in  an  earlier  study  (24).  This 
increase  is  small  and  affects  only  glycogenolysis  in  the 
liver  rather  than  lipolysis  (16). 
Another  point  merits  attention  here.  Noradrenergic 
stimulation  of  the  LHA  causes  a  decrease  of  FFA,  no 
change  of  glucose,  and  an  increase  of  insulin,  whereas 
adrenergic  stimulation  of the  LHA  elicits  an  increase  of 
glucose  and  insulin  and  no  change  of  FFA.  A  possible 
explanation  accounting  for  the  different  effects  of norad- 
renergic  and  adrenergic  stimulation  of the  LHA  on  FFA 
and  glucose  levels  might  be as follows.  The  LHA  contains 
three  separate  neuronal  circuits  involved  in  the  regula- 
tion  of  blood  glucose,  plasma  FFA,  and  insulin.  These 
separate  neuronal  circuits  contain  different  sets of recep- 
tors.  Most  probable,  ,&-receptors  are  present  in  the  cir- 
cuit  responsible  for  glucose  release  because  only  E  elicits 
the  response.  In  this  respect  it  has  to  be  borne  in  mind 
that  NE  has  a  markedly  reduced  potency  at  the  ,&- 
adrenoreceptor,  whereas  the  potency  of  E  and  NE  on 
al-,  a2-,  and  ,&-adrenoreceptors  are  more  or  less  equal. 
An  al-,  CQ-, or  ,&-adrenoreceptor  present  in  the  circuit 
involved  in  insulin  release  may  account  for  the  release 
of  insulin.  The  observation  that  NE  infusion  into  the 
LHA  suppresses  plasma  FFA,  whereas  E  infusion  is 
without  effect,  cannot  be  reconciled  easily  with  the  just 
mentioned  potency  of  NE  and  E  on  cyl-, CQ-, ,&-,  or  &- 
adrenoreceptors.  Further  investigation  is  needed  to  clar- 
ify  the  nature  of the  receptor  involved. 
Regarding  the  VMH,  it  is  also  likely  that  three  sepa- 
rate  neural  circuits  are  responsible  for  the  observed  ef- 
fects  on  plasma  FFA-insulin  and  blood-glucose  concen- 
trations.  Regarding  the  circuits  involved  in  insulin  and 
FFA  release,  again  stimulation  of cxl-, CQ-, or  pl-adreno- 
receptors  might  account  for  the  observed  increases.  With 
respect  to  FFA,  a ,&-receptor  mechanism  is  most  proba- 
bly  because  Barbosa  and  Migliorini  (2)  found  an  inhibi- 
tion  of  FFA  release  after  NE  injection  into  the  lateral 
brain  ventricle  only  if,  before  NE  administration,  the  p- 
blocker  propranolol  was  injected  into  the  cerebrospinal 
fluid.  The  observation  that  noradrenergic  stimulation  of 
the  VMH  causes  an  increase  in  blood  glucose  and  that 
adrenergic  stimulation  is  without  effect  cannot  be  clari- 
fied  with  the  current  concept  of  al-,  CY~-,  ,&-,  and  ,&- 
adrenoreceptor  stimulation  by  NE  and  E. 
We  find  a  similar  release  of  insulin  with  the  used 
dosage  of NE  and  E  (25  ng/min)  irrespective  of admin- 
istration  either  in  the  LHA  or  VMH.  In  previous  work 
we  reported  that  infusion  of  12.5  ng  NE/min  into  the 
LHA  elicits  insulin  release  (24,  25),  whereas  infusion  of 
12.5  ng  NE/min  into  the  VMH  was  without  effect  on 
insulin  (23).  The  finding  that  infusion  of a higher  dosage 
of  NE  into  the  VMH  elicits  insulin  release  whereas  a 
lower  dosage  is  without  effect  can  be  attributed  to  the 
spreading  of  infused  NE.  It  is  possible  that  the  neural 
circuit  involved  in  insulin  release,  which  is  definitely 
present  in  the  LHA  and  terminates  on  the  dorsal  motor 
nucleus  of  the  vagus  (13),  passes  the  VMH  on  a  short 
distance. 
Compared  with  data  in  the  literature,  our  basal  levels 
of  FFA  are  low  (-0.15,  peq/ml  plasma;  see  Table  1). 
However,  we sampled  just  at  the  beginning  of  the  day- 
light  period,  a time  at  which  lipogenesis,  which  is  maxi- 
mum  during  nighttime,  is  still  high  and  FFA  levels  are 
low (11).  Moreover,  the  subjects  were young  lean  animals, 
which  have  lower  insulin  levels  and  a  better  glucose 
tolerance  than  older  obese  ones.  Their  adipocytes  can 
take  up  glucose  more  easily,  and  this  in  turn  inhibits 
lipolysis  (26).  Finally,  we used  methods  of blood  sampling 
that  did  not  disturb  the  rats  and  therefore  minimized 
sympathetic  arousal  that  might  otherwise  elicit  lipolysis 
and  increases  of FFA  (cf. Fig.  3). 
Attention  has  to  be  paid  to  the  effects  of  infusion  of 
diluted  solvent  in  the  LHA  and  VMH.  In  contrast  to  its 
effects  on  glucose  and  insulin,  FFA  levels  increased 
slightly  during  infusion  of diluted  solvent.  This  was more 
pronounced  during  infusion  into  the  LHA  than  into 
VMH  (cf.  left  and  right  panels  of  Figs.  1  and  2).  A 
possible  explanation  might  be  that  irritation  of nervous 
tissue  in  LHA  and  VMH  occurs  that  is  caused  by  the 
flow  of  fluid,  an  inadequate  ionic  composition  of  the 
diluted  solvent,  or  a deviating  pH. 
The  most  intriguing  aspect  of this  study  is  the  unex- 
pected  increase  of  all  three  measured  substances,  i.e., 
insulin,  glucose,  and  FFA,  during  noradrenergic  and  ad- 
renergic  stimulation  of tne  VMH.  The  decrease  of FFA 
during  noradrenergic  stimulation  of the  LHA  might  be 
explained  by  the  simultaneous  increase  of  insulin,  but 
this  explanation  is  evidently  inadequate  because  norad- 
renergic  stimulation  of the  VMH  elicits  increases  of all 
three  parameters.  The  most  plausible  explanation  is that 
VMH  can  stimulate  lipolysis  and  also  increases  FFA 
independently  of the  levels  of glucose  and  insulin.  Very 
recent  data  in  the  literature  show,  first,  that  the  LHA 
can  manipulate  insulin  levels  without  changing  glucose 
and  glucagon  (25)  and,  second,  that  the  VMH  can  stim- 
ulate  glycogenolysis  I an .d glycogenesis  with  concomitant 
changes  in  glucose  ( 18)  independent  o f changes  in  either 
insulin  or  glucagon.  These  observations  have  very  im- 
portant  implications  regarding  regulation  of fuel  availa- 
bility  (i.e.,  glucose  and  FFA)  to  body  cells.  The  apparent 
close  correlation  between  glucose  and  FFA  and  their 
regulating  hormones  in  the  blood  circulation  (e.g.,  as 
occurs  during  eating  when  glucose  and  insulin  increase 
and  FFA  decrease)  can  be  completely  disrupted  by  inter- 
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important  during  arousal  of the  body,  e.g.,  physical  ac- 
tivity,  stress,  and  fasting  or  replenishment  of its  stores. 
Indications  in  literature  suggest  that  the  VMH  must  play 
an  important  role  in  this  regulation  because  lesioning  of 
the  VMH  interferes  with  fat  mobilization  during  both 
fasting  and  exercise  (4).  The  question  arises  as to  which 
pathways  are  involved  from  the  VMH  and  LHA  to  adi- 
pocytes.  Both  the  autonomic  nervous  system  and  hu- 
moral  factors  might  be  responsible.  The  idea  that  the 
VMH  can  arouse  the  sympathetic  system  and  the  LHA 
the  parasympathetic  system  (18) are  in  agreement  wi th 
the  decrease  of FFA  during  n  .orad renergic  stimulation  of 
the  LHA  and  the  increase  of FFA  during  adrenergic  and 
noradrenergic  stimulation  of the  VMH  described  in  this 
study.  However,  humoral  factors  cannot  be  excluded 
because  the  pituitary,  which  can  release  powerful  lipo- 
lytic  factors  such  as  lipotropines,  is  under  the  constant 
influence  of  the  hypothalamus.  Further  investigations 
are needed  to  unravel  the  roles  of the  autonomic  nervous 
system  and  hypothalamically  induced  humoral  factors  in 
the  regulation  of plasma  FFA. 
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